跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,115 条关于
“insulin aspart-fsan”
全部
9,115
临床试验
7,282
药物
493
机构
91
资讯
1,249
上个月
Meitheal Pharmaceuticals Announces FDA Approval of Garzulys™ (insulin aspart-fsan), a Biosimilar to NovoLog
去年
FDA Approves Kirsty as First Interchangeable Rapid-Acting Insulin Aspart Biosimilar
去年
Biocon Biologics and Civica Partner to Increase Affordable Insulin Aspart Access in US Market
去年
Wockhardt Seeks DCGI Approval for Fast-Acting Insulin Analog Aspart Injection
去年
Gan & Lee's Novel Diabetes Drugs GZR18, GZR4, and GZR101 Achieve Positive Phase 2 Results
去年
FDA Approves First Rapid-Acting Insulin Biosimilar Merilog for Diabetes Management
2个月前
Biocon and Duopharma Biotech Secure Over MYR 225 Million in Insulin Contracts from Malaysia's Ministry of Health
去年
Diabetes Pipeline Shows Robust Growth with 200+ Companies Developing Novel Therapies
4个月前
Sunshine Lake Pharma Becomes First Chinese Company to Secure FDA Approval for Insulin Glargine in US Market
8个月前
Sandoz Secures European Approval for Ondibta Insulin Glargine Biosimilar, Targeting 66 Million European Diabetes Patients
第 1 页,共 125 页
上一页
下一页